Development of an innovative pilot line and its validation under real conditions using synthesis process of a model active pharmaceutical ingredient.
Project no. POIR.01.01.01-00-0235/20
Utilisation of a matrix metalloprotease inhibitor to develop an innovative therapeutic method that prevents the development of post-traumatic and post-stroke epilepsy.
Project no. POIR.04.01.04-00-0063/20-00
Development of the innovative formulation of the combination drug dedicated for the geriatric patients in pain pharmacotherapy
Project no. TANGO-IV-C/0012/2019
Development of an innovative combined preparation dedicated for the treatment of hypertension.
Project no. RPWP.01.02.00-30-0047/19-00
Establishment of a R&D Laboratory of Super Generic Drugs.